Literature DB >> 8537483

Steroid hormone receptors and their clinical significance in cancer.

R I Nicholson1, R A McClelland, J M Gee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537483      PMCID: PMC502940          DOI: 10.1136/jcp.48.10.890

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  71 in total

1.  Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.

Authors:  R A McClelland; U Berger; L S Miller; T J Powles; R C Coombes
Journal:  J Clin Oncol       Date:  1986-08       Impact factor: 44.544

2.  Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion.

Authors:  B Lindahl; P Alm; M Fernö; H Grundsell; A Norgren; C Tropé
Journal:  Anticancer Res       Date:  1986 Nov-Dec       Impact factor: 2.480

3.  The prognostic importance of steroid receptors in endometrial carcinoma.

Authors:  D C Palmer; I M Muir; A I Alexander; M Cauchi; R C Bennett; M A Quinn
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661

Review 4.  Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.

Authors:  R I Nicholson; K J Walker; P Davies
Journal:  Cancer Surv       Date:  1986

5.  Sex hormone receptors in intracranial tumours and normal brain.

Authors:  I R Whittle; R A Hawkins; J D Miller
Journal:  Eur J Surg Oncol       Date:  1987-08       Impact factor: 4.424

6.  Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment.

Authors:  A Howell; R N Harland; D M Barnes; A D Baildam; M J Wilkinson; E Hayward; R Swindell; R A Sellwood
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

7.  Estrogen and progesterone receptor determination in the papillary cystic neoplasm of the pancreas. With immunohistochemical and ultrastructural observations.

Authors:  M Ladanyi; S Mulay; J Arseneau; P Bettez
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

8.  Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle.

Authors:  C Markopoulos; U Berger; P Wilson; J C Gazet; R C Coombes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-14

9.  Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis.

Authors:  N Wernert; J Gerdes; V Loy; G Seitz; O Scherr; G Dhom
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

10.  Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.

Authors:  A J Kauppila; H E Isotalo; S T Kivinen; R K Vihko
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

View more
  1 in total

Review 1.  Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.

Authors:  R I Nicholson; J M Gee
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.